Caribou Biosciences (CRBU) Operating Margin (2020 - 2025)
Historic Operating Margin for Caribou Biosciences (CRBU) over the last 6 years, with Q3 2025 value amounting to 1337.58%.
- Caribou Biosciences' Operating Margin rose 5516500.0% to 1337.58% in Q3 2025 from the same period last year, while for Sep 2025 it was 1708.08%, marking a year-over-year decrease of 2685800.0%. This contributed to the annual value of 1667.16% for FY2024, which is 13305300.0% down from last year.
- According to the latest figures from Q3 2025, Caribou Biosciences' Operating Margin is 1337.58%, which was up 5516500.0% from 1783.95% recorded in Q2 2025.
- Caribou Biosciences' 5-year Operating Margin high stood at 61.84% for Q3 2023, and its period low was 1893.87% during Q1 2024.
- Its 5-year average for Operating Margin is 1105.49%, with a median of 888.52% in 2023.
- Its Operating Margin has fluctuated over the past 5 years, first soared by 7484500bps in 2021, then tumbled by -18273900bps in 2024.
- Caribou Biosciences' Operating Margin (Quarter) stood at 797.38% in 2021, then dropped by -4bps to 828.22% in 2022, then decreased by -27bps to 1052.33% in 2023, then crashed by -78bps to 1871.69% in 2024, then increased by 29bps to 1337.58% in 2025.
- Its Operating Margin was 1337.58% in Q3 2025, compared to 1783.95% in Q2 2025 and 1823.76% in Q1 2025.